Premium
Combination chemotherapy followed by surgery or radiotherapy in patients with locally advanced cervical cancer
Author(s) -
KIRSTEN F.,
ATKINSON K.H.,
COPPLESON J. V. M.,
ELLIOTT P. M.,
GREEN D.,
HOUGHTON R.,
MURRAY J.C.,
RUSSELL P.,
SOLOMON H. J.,
FRIEDLANDER M.,
SWANSON C. E.,
TATTERSALL M. H. N.
Publication year - 1987
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.1987.tb03154.x
Subject(s) - medicine , chemotherapy , radiation therapy , vinblastine , bleomycin , cisplatin , cervical cancer , surgery , oncology , cancer
Summary Forty‐seven patients with locally advanced cervical cancer at high risk of relapse received three cycles of chemotherapy with PVB (cisplatin, vinblastine and bleomycin) before definitive local treatment with either radical surgery or radiotherapy. Thirty‐one of the 47 patients (66%) responded to initial chemotherapy, and 11 of them have relapsed compared with 13 of the 16 non‐responders. Median time to recurrence was 31 weeks for PVB non‐responders but has not yet been reached for PVB responders. After a median follow‐up of 128 weeks, 14 of the 31 responders (45 %) are alive and disease free compared with 3 of the 16 non‐responders (19%). There was a positive correlation between response to chemotherapy and subsequent response to radiotherapy. PVB was in general well tolerated although one death is probably attributable to chemotherapy. A randomized study comparing radiotherapy alone with initial PVB chemotherapy followed by radiotherapy is in progress.